Hints and tips:
...The contracts will give the UK access to 1.75m additional courses of Merck Sharp and Dohme’s antiviral Lagevrio and an extra 2.5m courses of Pfizer’s Paxlovid pill....
...That was a sharp increase from last year’s growth of 15 per cent and 16 per cent respectively....
...A spokesperson for Merck Sharp & Dohme – the name under which the US group operates in Europe – said it is cooperating fully with the CMA’s investigation, and said: MSD is confident that the proceedings...
...Mergers led the US company to become known as Merck Sharp & Dohme, which prompted a 1950s agreement for it to keep exclusive rights to the Merck name in North America while calling itself MSD everywhere...
...Mergers led the US company to become known as Merck Sharp & Dohme, and this spurred a 1950s agreement for it to keep exclusive rights to the family name in North America while calling itself MSD everywhere...
...To closures by Merck Sharp & Dohme, GlaxoSmithKline, Roche and Pfizer has now been added AstraZeneca’s re-organisation and reduction....
...Merck Sharp and Dohme, better known as MSD, has filed a case with Delhi’s High Court claiming that Glenmark, the Mumbai-listed pharmaceutical company, is violating patents on its diabetes drugs, Januvia...
...Merck Sharp and Dohme sells its patented diabetes drug Januvia in India for about $24 per month, 80 per cent lower than its global price....
...Last year, it bought Merck Sharp & Dohme’s Ponders End API manufacturing site in north London. It has not divulged details of either that deal or the Queenborough purchase....
...In what could be a coincidence, Switzerland’s Novartis was again being named as a possible bidder for drugs group SkyePharma, as were AstraZeneca and Merck of the US....
...Merck, meanwhile, jumped 6.8 per cent to €67.73 after the German drugs and chemicals group raised its profitability targets....
...Merck's stock saw limited action while Pfizer's was fractionally lower....
International Edition